The Claim
In animal models of colon cancer and melanoma, BPC 157 reduces tumor growth, inhibits metastasis, and counteracts cancer-related muscle wasting and weight loss through suppression of pro-inflammatory cytokines and modulation of the VEGF pathway.
What the research says
Not yet evaluated
We are still looking at what the research says.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In mice and other animal models with colon cancer or melanoma, BPC 157 decreases tumor size, prevents cancer spread, and stops muscle loss and weight loss by reducing inflammatory signaling molecules and altering VEGF pathway activity.
See the scientific wording
In animal models of colon cancer and melanoma, BPC 157 reduces tumor growth, inhibits metastasis, and counteracts cancer-related muscle wasting and weight loss, potentially through suppression of pro-inflammatory cytokines and modulation of the VEGF pathway.
BPC 157 stabilizes blood vessel function by balancing nitric oxide levels and blocking abnormal blood vessel growth in tumors. This cuts off the tumor's food supply, slows its spread, and prevents the body from breaking down muscle tissue. At the same time, it reduces harmful inflammation and protects nerves and tissues from damage caused by cancer.
What the research says
1 studyIn mice and rats, a substance called BPC 157 was shown to shrink tumors and help fix damaged blood vessels and tissues, which suggests it might slow cancer growth and protect the body from cancer’s harmful effects.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.